Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce G Pollock

Showing results (171-180 of 327) with videos related to

Pageof 33
Sort By:
Diabetes & Metabolic Syndrome|March 8, 2020
DAS: The Diabetes Awareness and Insight ScaleJulia Kim, Parita Shah, Lena C Quilty, et al.
The American Journal of Psychiatry|December 31, 2004
Efficacy and tolerability of citalopram in the treatment of late-life anxiety disorders: results from an 8-week randomized, placebo-controlled trialEric J Lenze, Benoit H Mulsant, M Katherine Shear, et al.
Therapeutic Drug Monitoring|April 8, 2009
Clozapine exposure and the impact of smoking and gender: a population pharmacokinetic studyWenzie Ng, Hiroyuki Uchida, Zahinoor Ismail, et al.
Medical Hypotheses|February 27, 2017
Impaired illness awareness and leftward visuospatial inattention in schizophrenia are attributable to a common neural deficit - Posterior parietal hemispheric imbalanceJulia Kim, Eric Plitman, Shinichiro Nakajima, et al.
Schizophrenia Research|June 26, 2012
Cholinergic pathways and cognition in patients with schizophrenia: a pilot studyTarek K Rajji, Tiffany W Chow, Aristotle N Voineskos, et al.
The Journal of Clinical Psychiatry|November 6, 2002
Risk factors for falls during treatment of late-life depressionJin H Joo, Eric J Lenze, Benoit H Mulsant, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 10, 2005
Accelerating symptom-reduction in late-life depression: a double-blind, randomized, placebo-controlled trial of sleep deprivationCharles F Reynolds, Gwenn S Smith, Mary Amanda Dew, et al.
Journal of Clinical Psychopharmacology|July 20, 2005
Trajectories of treatment response in late-life depression: psychosocial and clinical correlatesAriel G Gildengers, Patricia R Houck, Benoit H Mulsant, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 4, 2006
Persistence of neuropsychologic deficits in the remitted state of late-life depressionRishi K Bhalla, Meryl A Butters, Benoit H Mulsant, et al.
Dialogues in Clinical Neuroscience|January 28, 2009
Incomplete response in late-life depression: getting to remissionEric J Lenze, Meera Sheffrin, Henry C Driscoll, et al.
Pageof 33

Showing results (171-180 of 327) with videos related to

Sort By:
Pageof 33
Diabetes & Metabolic Syndrome|March 8, 2020
DAS: The Diabetes Awareness and Insight ScaleJulia Kim, Parita Shah, Lena C Quilty, et al.
The American Journal of Psychiatry|December 31, 2004
Efficacy and tolerability of citalopram in the treatment of late-life anxiety disorders: results from an 8-week randomized, placebo-controlled trialEric J Lenze, Benoit H Mulsant, M Katherine Shear, et al.
Therapeutic Drug Monitoring|April 8, 2009
Clozapine exposure and the impact of smoking and gender: a population pharmacokinetic studyWenzie Ng, Hiroyuki Uchida, Zahinoor Ismail, et al.
Medical Hypotheses|February 27, 2017
Impaired illness awareness and leftward visuospatial inattention in schizophrenia are attributable to a common neural deficit - Posterior parietal hemispheric imbalanceJulia Kim, Eric Plitman, Shinichiro Nakajima, et al.
Schizophrenia Research|June 26, 2012
Cholinergic pathways and cognition in patients with schizophrenia: a pilot studyTarek K Rajji, Tiffany W Chow, Aristotle N Voineskos, et al.
The Journal of Clinical Psychiatry|November 6, 2002
Risk factors for falls during treatment of late-life depressionJin H Joo, Eric J Lenze, Benoit H Mulsant, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 10, 2005
Accelerating symptom-reduction in late-life depression: a double-blind, randomized, placebo-controlled trial of sleep deprivationCharles F Reynolds, Gwenn S Smith, Mary Amanda Dew, et al.
Journal of Clinical Psychopharmacology|July 20, 2005
Trajectories of treatment response in late-life depression: psychosocial and clinical correlatesAriel G Gildengers, Patricia R Houck, Benoit H Mulsant, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 4, 2006
Persistence of neuropsychologic deficits in the remitted state of late-life depressionRishi K Bhalla, Meryl A Butters, Benoit H Mulsant, et al.
Dialogues in Clinical Neuroscience|January 28, 2009
Incomplete response in late-life depression: getting to remissionEric J Lenze, Meera Sheffrin, Henry C Driscoll, et al.
Pageof 33